Manufacturers

Three senior women hugging and laughing

With Lumicera, you can rest assured that we are committed to building and maintaining life-long partnerships to improve patient care. Patient health and quality of life are central to everything we do, and our advanced shipping and tracking capabilities enable worry-free fulfillment for patients and manufacturers alike. That’s why we are trusted to distribute more than three dozen Limited Distribution Drugs by major manufacturers.

Our other areas of expertise:

  • Strategic alignment with manufacturer partners
  • Data analytics and reporting expertise
  • Best-in-class clinical programs
  • Worry-free fulfillment

To learn more and to better understand how Lumicera can help you, click on the information below.

Featured Content

  • Oral Breast Cancer Therapy Interventions in an Integrated Health System Specialty Pharmacy

    This report analyzed the patient acceptance rate and reported outcomes when a pharmacist provided interventions for patients on oral targeted breast cancer therapies in a mail order integrated health system specialty pharmacy.

    September 29, 2025
    Learn More about Oral Breast Cancer Therapy Interventions in an Integrated Health System Specialty Pharmacy
  • ,

    Lumicera Health Services Selected as a Partner In-Network Specialty Pharmacy for Anzupgo® (delgocitinib) cream

    Lumicera Health Services announced today it will be participating in LEO Pharma’s Limited Distribution Network to dispense Anzupgo® (delgocitinib) Cream, the first and only FDA-approved treatment for moderate-to-severe Chronic Hand Eczema (CHE) in adults.

    September 25, 2025
    Learn More about Lumicera Health Services Selected as a Partner In-Network Specialty Pharmacy for Anzupgo® (delgocitinib) cream
  • 340B Savings: Delivering Better Outcomes for Specialty Pharmacy Patients

    This report explores the background of 340B covered entities, how they operate and the ways Lumicera’s clinical liaison team optimizes these programs for cost savings.

    September 23, 2025
    Learn More about 340B Savings: Delivering Better Outcomes for Specialty Pharmacy Patients